412 related articles for article (PubMed ID: 30279140)
1. The GDF11-FTO-PPARγ axis controls the shift of osteoporotic MSC fate to adipocyte and inhibits bone formation during osteoporosis.
Shen GS; Zhou HB; Zhang H; Chen B; Liu ZP; Yuan Y; Zhou XZ; Xu YJ
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3644-3654. PubMed ID: 30279140
[TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor 11 is a protective factor for osteoblastogenesis by targeting PPARgamma.
Zhang Y; Shao J; Wang Z; Yang T; Liu S; Liu Y; Fan X; Ye W
Gene; 2015 Feb; 557(2):209-14. PubMed ID: 25534870
[TBL] [Abstract][Full Text] [Related]
3. The m
Chen LS; Zhang M; Chen P; Xiong XF; Liu PQ; Wang HB; Wang JJ; Shen J
Acta Pharmacol Sin; 2022 May; 43(5):1311-1323. PubMed ID: 34462564
[TBL] [Abstract][Full Text] [Related]
4. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone shifts bone marrow stromal cells from osteoblasts to adipocytes by C/EBPalpha promoter methylation.
Li J; Zhang N; Huang X; Xu J; Fernandes JC; Dai K; Zhang X
Cell Death Dis; 2013 Oct; 4(10):e832. PubMed ID: 24091675
[TBL] [Abstract][Full Text] [Related]
6. MiR-27a is Essential for the Shift from Osteogenic Differentiation to Adipogenic Differentiation of Mesenchymal Stem Cells in Postmenopausal Osteoporosis.
You L; Pan L; Chen L; Gu W; Chen J
Cell Physiol Biochem; 2016; 39(1):253-65. PubMed ID: 27337099
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA Bmncr regulates mesenchymal stem cell fate during skeletal aging.
Li CJ; Xiao Y; Yang M; Su T; Sun X; Guo Q; Huang Y; Luo XH
J Clin Invest; 2018 Dec; 128(12):5251-5266. PubMed ID: 30352426
[TBL] [Abstract][Full Text] [Related]
8. GDF11 Inhibits Bone Formation by Activating Smad2/3 in Bone Marrow Mesenchymal Stem Cells.
Lu Q; Tu ML; Li CJ; Zhang L; Jiang TJ; Liu T; Luo XH
Calcif Tissue Int; 2016 Nov; 99(5):500-509. PubMed ID: 27395058
[TBL] [Abstract][Full Text] [Related]
9. Cultured Human Periosteum-Derived Cells Can Differentiate into Osteoblasts in a Perioxisome Proliferator-Activated Receptor Gamma-Mediated Fashion via Bone Morphogenetic Protein signaling.
Chung JE; Park JH; Yun JW; Kang YH; Park BW; Hwang SC; Cho YC; Sung IY; Woo DK; Byun JH
Int J Med Sci; 2016; 13(11):806-818. PubMed ID: 27877072
[TBL] [Abstract][Full Text] [Related]
10. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells.
Bäckesjö CM; Li Y; Lindgren U; Haldosén LA
J Bone Miner Res; 2006 Jul; 21(7):993-1002. PubMed ID: 16813520
[TBL] [Abstract][Full Text] [Related]
11. Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation.
Liu Y; Berendsen AD; Jia S; Lotinun S; Baron R; Ferrara N; Olsen BR
J Clin Invest; 2012 Sep; 122(9):3101-13. PubMed ID: 22886301
[TBL] [Abstract][Full Text] [Related]
12. Suppression of EZH2 Prevents the Shift of Osteoporotic MSC Fate to Adipocyte and Enhances Bone Formation During Osteoporosis.
Jing H; Liao L; An Y; Su X; Liu S; Shuai Y; Zhang X; Jin Y
Mol Ther; 2016 Feb; 24(2):217-229. PubMed ID: 26307668
[TBL] [Abstract][Full Text] [Related]
13. The miR-4739/DLX3 Axis Modulates Bone Marrow-Derived Mesenchymal Stem Cell (BMSC) Osteogenesis Affecting Osteoporosis Progression.
Li D; Yuan Q; Xiong L; Li A; Xia Y
Front Endocrinol (Lausanne); 2021; 12():703167. PubMed ID: 34925225
[TBL] [Abstract][Full Text] [Related]
14. The Fto Gene Regulates the Proliferation and Differentiation of Pre-Adipocytes in Vitro.
Jiao Y; Zhang J; Lu L; Xu J; Qin L
Nutrients; 2016 Feb; 8(2):102. PubMed ID: 26907332
[TBL] [Abstract][Full Text] [Related]
15. A new concept underlying stem cell lineage skewing that explains the detrimental effects of thiazolidinediones on bone.
Bruedigam C; Eijken M; Koedam M; van de Peppel J; Drabek K; Chiba H; van Leeuwen JP
Stem Cells; 2010 May; 28(5):916-27. PubMed ID: 20213769
[TBL] [Abstract][Full Text] [Related]
16. Orcinol glucoside facilitates the shift of MSC fate to osteoblast and prevents adipogenesis via Wnt/β-catenin signaling pathway.
Zhou X; Liu Z; Huang B; Yan H; Yang C; Li Q; Jin D
Drug Des Devel Ther; 2019; 13():2703-2713. PubMed ID: 31496649
[TBL] [Abstract][Full Text] [Related]
17. The Long Non-coding RNA-ORLNC1 Regulates Bone Mass by Directing Mesenchymal Stem Cell Fate.
Yang L; Li Y; Gong R; Gao M; Feng C; Liu T; Sun Y; Jin M; Wang D; Yuan Y; Yan G; He M; Idiiatullina E; Ma W; Han Z; Zhang L; Huang Q; Ding F; Cai B; Yang F
Mol Ther; 2019 Feb; 27(2):394-410. PubMed ID: 30638773
[TBL] [Abstract][Full Text] [Related]
18. PPARγ suppression inhibits adipogenesis but does not promote osteogenesis of human mesenchymal stem cells.
Yu WH; Li FG; Chen XY; Li JT; Wu YH; Huang LH; Wang Z; Li P; Wang T; Lahn BT; Xiang AP
Int J Biochem Cell Biol; 2012 Feb; 44(2):377-84. PubMed ID: 22120652
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-133a Regulates the Viability and Differentiation Fate of Bone Marrow Mesenchymal Stem Cells via MAPK/ERK Signaling Pathway by Targeting FGFR1.
Wang G; Wan L; Zhang L; Yan C; Zhang Y
DNA Cell Biol; 2021 Aug; 40(8):1112-1123. PubMed ID: 34165368
[TBL] [Abstract][Full Text] [Related]
20. Jabuticaba peel extract modulates adipocyte and osteoblast differentiation of MSCs from healthy and osteoporotic rats.
Souza ATP; Freitas GP; Lopes HB; Totoli GGC; Tarone AG; Marostica-Junior MR; Rosa AL; Beloti MM
J Bone Miner Metab; 2021 Mar; 39(2):163-173. PubMed ID: 32889573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
